Comparing oxidative stress in type 1 diabetes and LADA
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at oxidative stress—a type of cell damage—in people with type 1 diabetes or LADA. It may help explain how these conditions affect the body and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes or LADA (latent autoimmune diabetes in adults).
- You are between 18 and 75 years old.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common fatty liver disease is in people with type 1 diabetes and what might increase the risk. By joining, you could help doctors understand and better manage liver health for people with type 1 diabetes.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study is looking at how a sugar-processing protein, called GLUT1, affects the immune system in people with type 1 diabetes. It uses blood samples already stored in a biobank, so no new samples or treatments are needed from you.
This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.
This trial studies people who develop severe, fast-onset “type 1 diabetes” with body-wide stress (ketosis/ketoacidosis) soon after symptoms start. It aims to better understand this condition and how to care for it early.
This trial tests a hybrid closed-loop insulin pump system for people with LADA (a slow-progressing form of autoimmune diabetes). It aims to see if the system can improve blood sugar control and reduce hypoglycemia.
Hear when a new Latent Autoimmune Diabetes in Adult (LADA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.